SC06, a novel small molecule compound, displays preclinical activity against multiple myeloma by disrupting the mTOR signaling pathway
Kunkun Han(Soochow University), Xinliang Mao(Guangzhou University of Chinese Medicine)
Cited by 21
Related Papers
Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization
|Journal of Hematology & Oncology|2014|80
Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway
|Scientific Reports|2014|67
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
|Journal of Biological Chemistry|2019|62
Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis
|Acta Pharmacologica Sinica|2020|61
Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis
|Journal of Biological Chemistry|2019|57